Advances in encapsulating gonadotropin-releasing hormone agonists for controlled release: a review
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Microencapsulation"
DOI: 10.1080/02652048.2022.2100934
Abstract: Abstract Gonadotropin-releasing hormone (GnRH) agonists are peptides consisting of nine or ten amino acid residues. GnRH agonists have been applied in the therapy of sexual hormone disorders like prostate cancer, endometriosis, uterine myoma, central precious… read more here.
Keywords: releasing hormone; gonadotropin releasing; hormone; release ... See more keywords
Long-term adherence to GnRH agonists in men with prostate cancer. A nation-wide population-based study in prostate cancer data base Sweden
Sign Up to like & getrecommendations! Published in 2019 at "Scandinavian Journal of Urology"
DOI: 10.1080/21681805.2019.1702093
Abstract: Abstract Aim: Gonadotropin-releasing hormone (GnRH) agonists are used to treat men with prostate cancer (PCa). To date, no study has fully assessed patterns of adherence to GnRH agonists. We investigated patterns of adherence to GnRH… read more here.
Keywords: gnrh agonists; gnrh; prostate cancer; adherence gnrh ... See more keywords
Are all gonadotrophin‐releasing hormone agonists equivalent for the treatment of prostate cancer? A systematic review
Sign Up to like & getrecommendations! Published in 2018 at "BJU International"
DOI: 10.1111/bju.14168
Abstract: To review direct comparative studies of the gonadotrophin‐releasing hormone (GnRH) agonists goserelin, triptorelin, and leuprorelin for the treatment of prostate cancer, and identify whether there are meaningful clinical differences between these agents. In June 2017,… read more here.
Keywords: prostate; releasing hormone; gonadotrophin releasing; prostate cancer ... See more keywords
Editorial Comment to Treatment‐induced changes in levels of brain natriuretic peptide in prostate cancer patients receiving gonadotropin‐releasing hormone antagonists or agonists
Sign Up to like & getrecommendations! Published in 2020 at "International Journal of Urology"
DOI: 10.1111/iju.14214
Abstract: Androgen deprivation therapy (ADT) is a central part of prostate cancer treatment. Although medical castration using gonadotropin-releasing hormone (GnRH) agonists or antagonists might soften the mental or physical burden caused by surgical castration, an increase… read more here.
Keywords: hormone; treatment; prostate cancer; bnp levels ... See more keywords
Frozen thawed embryo transfer cycles; A comparison of pregnancy outcomes with and without prior pituitary suppression by GnRH agonists: An RCT
Sign Up to like & getrecommendations! Published in 2018 at "International Journal of Reproductive Biomedicine"
DOI: 10.29252/ijrm.16.9.587
Abstract: Background: To perform an in-vitro fertilization cycle, pretreatment with gonadotropin-releasing hormone (GnRH) agonist is widely used as a part of controlled ovarian hyper-stimulation protocols to prevent endogenous luteinizing hormone surge and spontaneous ovulation. GnRH agonist… read more here.
Keywords: frozen thawed; pregnancy; embryo transfer; rate ... See more keywords